Compound heterozygous UGT1A1*28 and UGT1A1*6 or single homozygous UGT1A1*28 are major genotypes associated with Gilbert ? s syndrome in Chinese Han people

被引:6
|
作者
Zhang, Meng [1 ]
Wang, Hongwu [1 ]
Huang, Yuancheng [1 ,2 ]
Xu, Xin [1 ]
Liu, Wei [1 ]
Ning, Qin [1 ]
Chen, Tao [1 ]
Qi, Junying [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept & Inst Infect Dis, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Phys Examinat Ctr, Wuhan, Hubei, Peoples R China
关键词
Hyperbilirubinemia; Genotype; Chinese people; CRIGLER-NAJJAR-SYNDROME; SERUM BILIRUBIN CONCENTRATIONS; UGT1A1; GENE-MUTATIONS; INHERITED DISORDERS; NEONATAL HYPERBILIRUBINEMIA; UDP-GLUCURONOSYLTRANSFERASE-1; VARIANTS; PROMOTER; POLYMORPHISM; METABOLISM;
D O I
10.1016/j.gene.2021.145526
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Gilbert?s syndrome (GS) is a mild condition characterized by periods of hyperbilirubinemia, which results in variations in the UDP-glucuronosyltransferase 1 (UGT1A1) gene. Variant genotypes of UGT1A1 vary in different populations in the world. The present study aimed to determine the genotype of the UGT1A1 promoter and exon that are related to the serum total bilirubin (STB) level in the Chinese Han population. A total of 120 individuals diagnosed with GS (GS group) and 120 healthy individuals (non-GS group) were enrolled. Routine blood, liver function tests, and antibodies associated with autoimmune liver diseases were assessed. Blood samples were collected for DNA purification. Sequencing of the UGT1A1 promoter and exons was conducted for post segment amplification by PCR. Compound heterozygous UGT1A1*28 and UGT1A1*6 (25/120, 20.83%), single homozygous UGT1A1*28 (24/120, 20.00%) and single heterozygous UGT1A1*6 (18/120, 15.00%) were the most frequent genotypes in the GS group. However, single heterozygous UGT1A1*6 (30/120, 25.00%) and single heterozygous UGT1A1*28 (19/120, 15.83%) were the most frequent genotypes in the non-GS group. Further, the frequencies of single homozygous UGT1A1*28, compound heterozygous UGT1A1*28 and UGT1A1*6, and compound heterozygous UGT1A1*28, UGT1A1*6 and UGT1A1*27 were significantly higher in the GS group than those in the non-GS group. The STB levels of GS patients with the homozygous UGT1A1*28 genotype were remarkably higher than those of patients with other genotypes. Homozygous UGT1A1*28 and heterozygous UGT1A1*6 variants were associated with the highest and lowest risks of hyperbilirubinemia, respectively. Our study revealed that compound heterozygous UGT1A1*28 and UGT1A1*6, or single homozygous UGT1A1*28 are major genotypes associated with GS in Chinese Han people. These findings might facilitate the precise genomic diagnosis of Gilbert?s syndrome.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] UGT1A1*28 polymorphism influences glucuronidation of bazedoxifene
    Lusin, T. Trdan
    Mrhar, A.
    Trontelj, J.
    PHARMAZIE, 2015, 70 (02): : 94 - 96
  • [32] Recurrent cervical cancer in a patient who was compound heterozygous for UGT1A1*6 and UGT1A1*28 presenting with serious adverse events during irinotecan hydrochloride/nedaplatin therapy
    Takatori, Eriko
    Shoji, Tadahiro
    Miura, Yuki
    Takeuchi, Satoshi
    Yoshizaki, Akira
    Sugiyama, Toru
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2013, 39 (08) : 1354 - 1358
  • [33] Inhibition of UGT1A1*1 and UGT1A1*6 catalyzed glucuronidation of SN-38 by silybins
    Li, Wei
    Chen, Yin-Nan
    Chen, Yue-Yue
    Wang, Zhe
    Wang, Zhen
    Jiang, Li-Li
    Shi, Hong-Can
    Liu, Yong
    CHEMICO-BIOLOGICAL INTERACTIONS, 2022, 368
  • [34] Effects of UGT1A1*6, UGT1A1*28, and ABCB1-3435C>T polymorphisms on irinotecaninduced toxicity in Chinese cancer patients
    Yan, Liang
    Wang, Xiao-fei
    Wei, Lu-man
    Nie, Ya-li
    Liu, Jing-yang
    Zhang, Li-rong
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2016, 54 (03) : 193 - 199
  • [35] The Development of UGT1A1 and UGT1A6 in Pediatric Liver
    Miyagi, Shogo J.
    Abby, C.
    DRUG METABOLISM REVIEWS, 2009, 41 : 17 - 18
  • [36] Humanized UGT1*28 Mice for Assessing UGT1A1 dependent glucuronidation and Clearance
    Yang, Young-Sun
    Peterkin, Vincent
    Cai, Hongliang
    Hotz, Kathy
    Nguyen, Nghia
    La Placa, Deirdre
    Tukey, Robert H.
    Stevens, Jeffrey C.
    DRUG METABOLISM REVIEWS, 2009, 41 : 39 - 40
  • [37] A study of the association between UGT1A1*28 variant allele of UGT1A1 gene and colonic phenotype of sporadic colorectal cancer
    Anon, Benjamin
    Perray, Clemence
    Regnault, David
    Caulet, Morgane
    Orain, Isabelle
    Godart, Bruno
    Pages, Jean-Christophe
    Tallet, Anne
    Ouaissi, Mehdi
    Guyetant, Serge
    Barin-le Guellec, Chantal
    Lecomte, Thierry
    DIGESTIVE AND LIVER DISEASE, 2019, 51 (04) : 579 - 583
  • [38] UGT1A1*6 AND UGT1A1*27 ARE ASSOCIATED WITH IRINOTECAN-INDUCED SEVERE NEUTROPENIA IN JAPANESE PATIENTS WITH NSCLC
    Doi, S.
    Nakamura, Y.
    Fukuda, M.
    Takatani, H.
    Fukuda, M.
    Kinoshita, A.
    Soda, H.
    Oka, M.
    Tsukamoto, K.
    Kohno, S.
    ANNALS OF ONCOLOGY, 2008, 19 : 165 - 165
  • [39] The role of UGT1A1 polymorphisms (☆28 and ☆6) in Japanese cancer patients
    Morimoto, S.
    Shimada, M.
    Kurita, N.
    Iwata, T.
    Nishioka, M.
    Yoshikawa, K.
    Miyatani, T.
    Mikami, C.
    Kashihara, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [40] UGT1A1*28 is Associated with Decreased Systemic Exposure of Atorvastatin Lactone
    Camilla Stormo
    Martin P. Bogsrud
    Monica Hermann
    Anders Åsberg
    Armin P. Piehler
    Kjetil Retterstøl
    Marianne K. Kringen
    Molecular Diagnosis & Therapy, 2013, 17 : 233 - 237